<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01484886</url>
  </required_header>
  <id_info>
    <org_study_id>38569</org_study_id>
    <nct_id>NCT01484886</nct_id>
  </id_info>
  <brief_title>Restrictive Versus Liberal Transfusion Protocol in Infants Undergoing Cardiac Surgery</brief_title>
  <official_title>Prospective Randomized Controlled Clinical Trial Comparing a Restrictive Versus Liberal Transfusion Strategy in Neonates and Infants Undergoing Surgery for Congenital Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In neonates and infants &lt;/= 10 kg following cardiac surgery for congenital heart disease a
      more restrictive red blood cell (RBC) transfusion strategy will be as effective as, and
      possibly superior to, a liberal RBC strategy. Allowing lower hemoglobin concentration will
      not affect the cardiac or pulmonary status of the patient.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>oxygen utilization derived from the arterio-venous oxygen difference.</measure>
    <time_frame>3 days</time_frame>
    <description>Arterial and venous oxygen saturations will be measured every four hours x 48-72 hours and will be used to calculate arterio-venous oxygen content differences.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>volume of RBC transfused</measure>
    <time_frame>7 days</time_frame>
    <description>The total numbers of RBC transfusions given during the immediate post-op period (1st 7 days) will be compared between groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">162</enrollment>
  <condition>Impaired Oxygen Delivery</condition>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>Restrictive transfusion strategy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RBC will be transfused if the hemoglobin level falls below 7 for bi-ventricular repairs and under 9.0 for single ventricle palliations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liberal RBC transfusion strategy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RBCs will be transfused for Hemoglobin under 9.5 for biventricular repairs and under 12 for single ventricle palliations.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Red blood cell transfusion</intervention_name>
    <description>10cc/kg weight RBC transfusion as needed according to hemoglobin level</description>
    <arm_group_label>Restrictive transfusion strategy</arm_group_label>
    <arm_group_label>Liberal RBC transfusion strategy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Red blood cell transfusion</intervention_name>
    <description>10cc/kg body weight RBC will be transfused for hemoglobin under 9.5 for biventricular repairs and under 12 for single ventricle palliations.</description>
    <arm_group_label>Liberal RBC transfusion strategy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children &lt;/= 6 months of age with congenital cardiac disease undergoing cardiac
             surgery with cardiopulmonary bypass.

        Exclusion Criteria:

          -  presence of a known bleeding disorder or coagulopathy.

          -  age &gt; 6 months,

          -  lack of informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2011</study_first_submitted>
  <study_first_submitted_qc>November 30, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2011</study_first_posted>
  <last_update_submitted>September 4, 2014</last_update_submitted>
  <last_update_submitted_qc>September 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>jill cholette</investigator_full_name>
    <investigator_title>Assistant Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Hemoglobin</keyword>
  <keyword>Congenital heart disease</keyword>
  <keyword>Cardiac surgery</keyword>
  <keyword>Red blood cell transfusion</keyword>
  <keyword>Number of red blood cell transfusions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

